Monday, 24 October 2022
| 08:50 – 09:50 | Registration and Refreshments | |
| 09:50 – 10:00 | Opening Remarks | |
| Session 1 | ||
| 10:00 – 10:30 | Treat-to-Target in Systemic Lupus Erythematosus (SLE): State of the Art | Eric Morand |
| 10:30 – 11:00 | CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus (SLE) | Januario Castro |
| 11:00 – 11:15 | Panel Discussion | |
| 11:15 – 11:35 | ADARRCTM Refreshment Break & Networking (ARBN) | |
| Session 2 | ||
| 11:35 – 12:05 | ANA as the Key Criterion for Systemic Lupus Erythematosus (SLE) Classification | Pier Luigi Meroni |
| 12:05 – 12:35 | The Use of Glucocorticoids in Systemic Lupus Erythematosus (SLE) after 60 Years: Still More an Art than Science | Johannes W.J. Bijlsma |
| 12:35 – 12:50 | Panel Discussion | |
| 12:50 – 14:00 | Lunch | |
| Session 3 | ||
| 14:00 – 14:30 | Measuring Glucocorticoid Toxicity | Johannes W.J. Bijlsma |
| 14:30 – 15:00 | Towards a Replacement for Glucocorticoids in Systemic Lupus Erythematosus (SLE) – A Molecular Solution | Eric Morand |
| 15:00 – 15:30 | CAR-T Cell Therapy: New Hope for Systemic Lupus Erythematosus (SLE) Patients | Januario Castro |
| 15:30 – 15:45 | Panel Discussion | |
| 15:45 | Closing Remarks | |
| END OF ADARRCTM LUPUS SUMMIT | ||